You searched for "Laser"
Sickle cell eye disease: an overview of vitreoretinal complications and their surgical management
1 December 2016
| Antonio Berarducci, Tom Williamson
|
EYE - Vitreo-Retinal
Sickle cell disease is the most common genetic disorder worldwide and is associated with lifelong anaemia, intermittent pain and multi-organ morbidity. Ocular involvement can be associated with significant visual impairment due to the complications of proliferative sickle retinopathy (PSR). Occasionally...
Rotational stability of angle supported phakic IOL
The authors evaluate 50 eyes of 28 patients that underwent an angle fixated phakic intraocular lens (IOL) implantation (Acrysof Cachet). All eyes had moderate to high myopia (-5.25 to-19.63 dioptres) and IOL sizing was performed as per the manufacturer’s recommendation....Efficacy of IVC injection in the treatment of ROP
2 December 2019
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a retrospective consecutive case series of patients who received intravitreal conbercept (IVC) as a primary treatment from June 2015 to July 2016 for treatment of retinopathy of prematurity (ROP). Forty-eight eyes of 24 patients were included in the...
Oral omega-3 fatty acid treatment for dry eye in contact lens wearers
This study evaluates the effect of dietary omega-3 fatty acid supplementation of dry eye symptoms, tear film tests, and conjunctival impression cytology in patients with contact lens wear-associated dry eye. In this randomised double-blind, multi-centred trial, contact lens wearers (n=...Mainline Instruments Appointed Distributor Partner by InMode for Envision
27 February 2025
|
Contracts & Distributors
Mainline Instruments is excited to announce a new partnership with InMode, a globally recognised leader in IPL, Laser, and Radiofrequency medical technologies, to distribute their prestigious Envision Dry Eye care platform throughout the UK and Ireland. InMode is known for...
Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...Mike Harris, family optometrist, takes office as Master of The Worshipful Company of Spectacle Makers
Optometrist Mike Harris was installed this week as Master of The Worshipful Company of Spectacle Makers, a fitting culmination to his career supporting better vision for all. Mike qualified with The Worshipful Company of Spectacle Makers in the late 1970s,...Incidence, characteristics and risk factors for ROP
This is a retrospective study performed at Seoul St Mary’s Hospital between the period of January 2009 to December 2013. The study was to determine the incidence and clinical features of, and risk factors for, retinopathy of prematurity (ROP) in...Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice
1 February 2015
| Pearse A Keane (Prof), Adnan Tufail
|
EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...
Transforming eyecare with AI at 100% Optical
4 March 2024
|
Pearse Keane, AI, Moorfields, UCL, technology, advancement, artificial intelligence, development
“We are drowning in people we need to see in hospital eye services, and some people are going blind as a result. We are looking at nearly 10m hospital appointments for ophthalmology a year, with an approximately 33% increase over...
Report: UKISCRS 2023
15 November 2023
| Samuel Verdin
|
UKISCRS, Cataract surgery, refractive surgeons, Gill Wood, London, Events, Conferences, 2023
An Eye News exclusive report of The 47th Annual Congress of the United Kingdom & Ireland Society of Cataract & Refractive Surgeons.